共 141 条
- [1] Davis GL(1989)Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized controlled study N Engl J Med 321 1501-1506
- [2] Balart LA(1995)Hepatic hepatitis C virus RNA as a predictor of long term response to interferona therapy Ann Intern Med 122 586-591
- [3] Schiff ER(1995)A comparison of three interferon alfa-2b regimens for the long term treatment of chronic non-A, non-B hepatitis N Engl J Med 332 1457-1462
- [4] Shindo M(1996)Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration Hepatology 24 778-789
- [5] Arai K(1997)Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa Hepatology 26 226-231
- [6] Sokawa Y(1990)Molecular action of ribavirin Rev Infect Dis 12 1132-1146
- [7] Okuna T(1998)Ribavirin inhibits viral induced macrophage production of tumor necrosis factor, interleukin 1, and procoagulant activity and preserves TH1 cytokine production, but inhibits TH2 cytokine response J Immunol 160 3487-3493
- [8] Poynard T(1998)Alfa-interferon and ribavirin vs alfa-interferon alone as therapy for chronic hepatitis C: a randomized, double-blind, placebo-controlled study Lancet 351 83-87
- [9] Bedossa P(1997)Early changes in HCV RNA kinetics with interferon and ribavirin compared to interferon alone suggest an additive antiviral effect with ribavirin [abstract] Hepatology 26 367A-367A
- [10] Chevallier M(1998)Daily high-dose interferon suppresses viremia in patients with chronic hepatitis C without a previous sustained response to standard treatment [abstract] Gastroenterology 114 A1248-A1248